Video Experimental Relacionado
Updated: Jul 15, 2026
09:41
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
Los dominios que especifican la interacción entre la trombina y los receptores
T K Vu1, V I Wheaton, D T Hung
1Cardiovascular Research Institute, University of California, San Francisco 94143-0524.
Nature
|October 17, 1991
Resumen
Los investigadores diseñaron un nuevo receptor de trombina activado por la enterokinasa, no por la trombina. Este estudio revela conocimientos clave sobre la activación del receptor de trombina y posibles nuevos objetivos farmacológicos para la trombosis.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Biología Molecular Biología Molecular
- Farmacología Farmacología.
Sus antecedentes:
- La activación plaquetaria por la trombina es crucial en la trombosis arterial.
- El receptor de trombina plaquetaria (PAR1) es un receptor de siete dominios transmembrana.
- La trombina divide el dominio extracelular del receptor para iniciar la señalización.
Objetivo del estudio:
- Para investigar los elementos esenciales para la activación del receptor de trombina.
- Para diseñar un receptor de trombina modificado con propiedades de activación alteradas.
- Para aclarar la base estructural de la alta afinidad y potencia de la trombina.
Principales métodos:
- Mutagénesis dirigida al sitio para reemplazar el sitio de escisión de la trombina con un sitio de escisión de la enterokinasa.
- Análisis funcionales para medir la activación del receptor por la enterokinasa y la trombina.
- Análisis estructural para identificar los dominios involucrados en la unión de la trombina.
Principales resultados:
- Se creó con éxito un receptor funcional de enterokinasa, lo que demuestra que la proteólisis es suficiente para la activación.
- El receptor diseñado requería concentraciones de enterokinasa nanomolar, a diferencia de la trombina picomolar para el receptor de tipo salvaje.
- Se identificó un dominio receptor específico, que imita la cola carboxílica de la hirudina, como crítico para la potente unión de la trombina a través de su exosito de unión aniónica.
Conclusiones:
- La proteólisis del receptor es el único determinante para la activación del receptor de trombina.
- Se estableció un modelo para la interacción entre la trombina y el receptor, destacando un dominio similar a la hirudina.
- Este modelo facilita el diseño de nuevos inhibidores de la trombina para el tratamiento de la trombosis.
Videos de Conceptos Relacionados
00:49The Blood-brain Barrier
Overview
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
01:15Blood Transfusion
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
01:30Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...